Dear Minister Bruins, there really is such a thing as lifestyle medicine

2 May 2018 • 4 min reading time

You recently responded to a motion by Ms Corinne Ellemeet by saying: “There is no such thing as lifestyle medicine”. Well, we can tell you that you’ve been misinformed, and we’d like to put that right.

Let’s start with the Van Dale dictionary’s definition of ‘medicine’: the science that identifies the cause and nature of diseases and indicates the appropriate medications (= curative substance, medicine). And let’s apply that definition to lifestyle-related diseases, using type 2 diabetes as a prototype. We have identified the most important cause of this disease – which is lifestyle. Solid scientific evidence has now pinpointed the best medicine for this disease – lifestyle modification is by far and away the most effective cure. In fact, lifestyle is the sole medicine for type 2 diabetes, as it is the only way to cure this disease completely. All other medicines – i.e. pills and insulin – reduce blood glucose levels, but do nothing to resolve the underlying problems. So they are not a cure.

Interaction between genes and lifestyle

To put it even more succinctly: pharmaceutical preparations do not comply with the definition of a medicine. So, in this case, lifestyle has to be seen as medicine rather than prevention. Incidentally, almost all chronic, non-communicable diseases (which affect 8.5 million people in the Netherlands) are the result of interactions between our genes and our lifestyle. We can’t modify our genes, but we can do something about our lifestyle.

“Lifestyle is the sole medicine for type 2 diabetes, as it is the only way to cure this disease completely”

No place for lifestyle medicine

Perhaps you meant, “No use is being made of lifestyle medicine”. That would be a more accurate statement. Lifestyle medicine has no place in the everyday reality of Dutch healthcare. There are historical reasons for this. We tend to wait until people get sick, and then expect doctors to solve the problem with a pill or an operation. That healthcare model worked just fine – a hundred years ago. Then, our biggest problems were infectious diseases and accidents.

Healthcare model no longer fit for purpose

Today, most diseases are very different in nature. They tend to be complex, systemic disorders that are often triggered by unhealthy lifestyles. The old model is no longer fit for purpose. Doctors have no time for lifestyle coaching, nor is there an effective reimbursement scheme, because the effects of laws and regulations are compartmentalized into ‘care’ and ‘prevention’. As a result, insurers refuse to formally reimburse the costs of lifestyle medicine under the Healthcare Insurance Act, local authorities are unable to comply with their duties under the Social Support Act (Wmo) and everyone points the finger at ‘the system’, i.e. at you. At the end of the day, it is the people with type 2 diabetes who pay the price.

“I hope you won’t let the business community tell us how to run our healthcare system”

One thirteenth of the cost

You know, you are about the same age as we are. If we three were to develop type 2 diabetes today – and the figures show that, even at our age, this is not unrealistic – then the total cost of treating us for the rest of our lives would be about 130,000 euros each. In our case, a lifestyle medicine programme would cost around 10,000 euros, or just 1/13th of that amount! To say nothing of the personal and social benefits of being less severely ill or, indeed, entirely healthy. Hardly a difficult choice, right? Where there are winners, there are, of course, losers. We would not need nearly as many pills, and the loss of potential patients would impact the health service financially. But I hope you won’t let the business community tell us how to run our healthcare system. 

Research agenda

Lifestyle medicine: there really is such a thing! Of course, we don’t yet have supporting evidence for every single lifestyle-related disease. Nor will lifestyle medicine cure every single patient. So, if we are to develop effective lifestyle medicine, in the broadest possible sense, we will need an effective research agenda. Together with counterparts in the Netherlands, we’d be happy to get involved in this. But research alone is not enough.

“Substantial modifications will be needed if the healthcare system is to tackle diseases that can be cured by lifestyle changes From care to cure. And from the consulting room to the living room”

From care to cure

Substantial modifications will be needed if the healthcare system is to tackle diseases that can be cured by lifestyle changes. From care to cure. And from the consulting room to the living room. We need a system that enables members of the public/patients to take control of their own health, 365 days a year. You are responsible for the system. You have it in your power to facilitate the use of lifestyle medicine in the Netherlands. The ball is in your court!

On behalf of the Netherlands Institute for Lifestyle Medicine,

Ben van Ommen (Principal Scientist at TNO)
Hanno Pijl (Professor of Diabetes at Leiden University Medical Centre – LUMC)

More information?

For more information, please contact Ben van Ommen

in the workplace

Excellent research: the risks of extreme heat and cold

11 Mar '20 - 3 min
What are the risks of heat or cold during physical exertion? This is what Boris Kingma researches and models at TNO. In doing so, he combines physics with human... Read more
facts & figures

TNO has a positive impact on the output of businesses

18 Nov '19 - 4 min
TNO’s mission is to connect people and knowledge to create innovations that sustainably boost the competitive strength of industry and the wellbeing of society.... Read more

D-score: worldwide insight into the development of children

20 Mar '19 - 3 min
Many children around the world are still lagging behind in their first five years of life, due to poor nutrition, insufficient care, and too few learning opportunities.... Read more
future view

Stay healthy, and in control of your data

5 Feb '19 - 1 min
Nowadays, the benefits of the Internet and digital innovation are permeating into practically every area of our lives and we are amassing vast volumes of data. Is... Read more
customer experiences

Microtracing with AMS technology leads to faster drug development

1 Feb '19 - 5 min
TNO’s advanced AMS technology (Accelerator Mass Spectrometer) enables faster drug development. AMS is being used successfully by partner Pfizer. The pharmaceutical... Read more


Stay up to date with our latest news, activities and vacancies collects and processes data in accordance with the applicable privacy regulations for an optimal user experience and marketing practices.
This data can easily be removed from your temporary profile page at any time.
You can also view our privacy statement or cookie statement.